Research articlePublished 4 Nov 2020

Secondary Hemophagocytic Syndrome: Differences between the Etiologies Autoimmunes and Hematological Malignancies Subgroup

Authors: César Antonio Egües Dubuc, Jaime Calvo-Alen, Lizbeth Patricia Cabrera- Miranda, Andrea De Diego Sola, José Ramon Furundarena Salsamendi, Nerea Alcorta Lorenzo, Jesús Alejandro Valero Jaimes, Luis María López Dominguez, Jorge Jesús Cancio Fanlo, Olga Maiz Alonso, Esther Uriarte Isacelaya, Joaquín María Belzunegui Otano

Journal of Rare Disorders: Diagnosis & Therapy

Volume 6 · Issue 6 · Pages 15

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: Hemophagocytic Syndrome (HPS) is an uncommon disorder with high mortality. HPS is reported to be usually related to some underlying conditions; autoimmune (AI) and hematological malignancies (HM) are two main underlying conditions. Here, we attempted to determine the clinical characteristics/ differences of HPS according to underlying conditions; AI vs. HM, based on our experience. Methods: We studied all adult patients with HPS diagnosed at our institution from 2005 to 2019. Demographic, clinical characteristics, laboratory findings, underlying disorders, hospital stay and prognosis variables were examined and related to the underlying conditions. Results: A total of 30 patients (median age of 55 years and male/female of 14/16) met the inclusion criteria which we analyzed: HM: 12 (40%), AI: 10 (33%), and others: 8 (27%). HM group, compared with AI group, showed a significantly longer length hospital stay (HM vs. AI: 61.5 vs. 30.5 (median)), more severe thrombocytopenia, leukocytopenias, and neutropenia, and importantly, higher mortality (with overall mortality and HM-related HPS-mortality being 43.3% and 66.7%, respectively). Contrarily, HM group, compared with AI group, showed less severe liver abnormalities (AST; 106 vs. 457 (median): ALT; 109 vs. 457 (median)). Conclusion: The HM subgroup presented a greater mortality and a higher number and severe cytopenias but lower elevation of transaminases.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. EuroSciCon does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Rare Disorders: Diagnosis & Therapy
  • SubjectHaematology
  • SubjectImmunology & Microbiology
  • BylineArticles whose byline prints “César Antonio Egües Dubuc”
  • BylineArticles whose byline prints “Jaime Calvo-Alen”
  • BylineArticles whose byline prints “Lizbeth Patricia Cabrera- Miranda”
  • BylineArticles whose byline prints “Andrea De Diego Sola”
  • BylineArticles whose byline prints “José Ramon Furundarena Salsamendi”
  • BylineArticles whose byline prints “Nerea Alcorta Lorenzo”
  • BylineArticles whose byline prints “Jesús Alejandro Valero Jaimes”
  • BylineArticles whose byline prints “Luis María López Dominguez”